Style | Citing Format |
---|---|
MLA | Kalhori MR, et al.. "The Potential Role of Mir-1290 in Cancer Progression, Diagnosis, Prognosis, and Treatment: An Oncomir or Onco-Suppressor Microrna?." Journal of Cellular Biochemistry, vol. 123, no. 3, 2022, pp. 506-531. |
APA | Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J (2022). The Potential Role of Mir-1290 in Cancer Progression, Diagnosis, Prognosis, and Treatment: An Oncomir or Onco-Suppressor Microrna?. Journal of Cellular Biochemistry, 123(3), 506-531. |
Chicago | Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J. "The Potential Role of Mir-1290 in Cancer Progression, Diagnosis, Prognosis, and Treatment: An Oncomir or Onco-Suppressor Microrna?." Journal of Cellular Biochemistry 123, no. 3 (2022): 506-531. |
Harvard | Kalhori MR et al. (2022) 'The Potential Role of Mir-1290 in Cancer Progression, Diagnosis, Prognosis, and Treatment: An Oncomir or Onco-Suppressor Microrna?', Journal of Cellular Biochemistry, 123(3), pp. 506-531. |
Vancouver | Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J. The Potential Role of Mir-1290 in Cancer Progression, Diagnosis, Prognosis, and Treatment: An Oncomir or Onco-Suppressor Microrna?. Journal of Cellular Biochemistry. 2022;123(3):506-531. |
BibTex | @article{ author = {Kalhori MR and Soleimani M and Arefian E and Alizadeh AM and Mansouri K and Echeverria J}, title = {The Potential Role of Mir-1290 in Cancer Progression, Diagnosis, Prognosis, and Treatment: An Oncomir or Onco-Suppressor Microrna?}, journal = {Journal of Cellular Biochemistry}, volume = {123}, number = {3}, pages = {506-531}, year = {2022} } |
RIS | TY - JOUR AU - Kalhori MR AU - Soleimani M AU - Arefian E AU - Alizadeh AM AU - Mansouri K AU - Echeverria J TI - The Potential Role of Mir-1290 in Cancer Progression, Diagnosis, Prognosis, and Treatment: An Oncomir or Onco-Suppressor Microrna? JO - Journal of Cellular Biochemistry VL - 123 IS - 3 SP - 506 EP - 531 PY - 2022 ER - |